What a great collaborative effort. Proud to be a part of it OncoAlert OncoAlert

Congratulations well deserved! OncoAlert

Congratulations to @dkatesharbeck for receiving an asuna conquer cancer award for his abstract #OncoAlert

Encouraging efficacy!

Proud Mom moment yesterday with daniel giving his first ASCO presentation @dkatesharbeck OncoAlert #ASCO24

Great news for patients #ASCO24 OncoAlert

Great effort! OncoAlert

Very good and balanced discussion by Dr. Krop today. Hopefully we will get the approval extension soon so that we can individualize treatment with TDXd in HER2-low MBC like he suggested in his algorithm OncoAlert

WSG proudly presents the ADAPT HER2 IV trial. Already 36 patients enrolled in this neoadjuvant deescalation trial with TDXd in HER2+ EBC. @dkatesharbeck OncoAlert

Fantastic news for patients! OncoAlert

It’s a privilege to wrap up #ASCO24 for our patients Renate Haidinger #OncoAlert

Fantastic #ASCO24 great connecting again. Hope everyone got home safe. See you all at #ESMO in Barcelona #OncoAlert

Please don’t forget to join us today Wednesday June 5 6:30 pm CEST for another #myESMO breast cancer deep dive webinar #oncoalert

Congratulations Felix Feng for this well deserved @ASTRO Award. Such a privilege to be working on amazing science together with Felix. #OncoAlert

Great discussion last night on personalized prevention and detection of breast cancer. You can still watch it on demand and collect points towards your #myESMO certificate of professional development. #OncoAlert

Couldn’t agree more. Fantastic work by #myriamChalabi and colleagues #Oncoalert

Dear Colleagues, The ESMO - Eur. Oncology Presidential Elections are going on LAST Day to VOTE is June 10th (noon CET) REMINDER THAT ALL VOTES ARE CONFIDENTIAL & NO ONE CAN SEE WHO YOU VOTE FOR esmo.org/about-esmo/how… Election Security is something ESMO takes very seriously to have a FAIR

Glad Kathrin Carl P. Heinrich views us this way. The purpose of a role model should be to help others grow and advance themselves by positive support and encouragement #OncoAlert

Chairing an Oxford discussion on Ki67 at the Annual German Senology Conference. Amazing to see that about 70% of the breast centers use endocrine response assessment in clinical routine according to WSG ADAPT. #OncoAlert

Welcome to Munich #myESMOGI24 looking forward to an exciting. Scientific exchange #OncoAlert